Some buy side analysts are also providing their Analysis on Interpace Diagnostics Group, Inc., where Estimate analysts have rated the stock as Strong buy, 32.35 said it’s a HOLD, 32.62 reported it as Underperform and 33.2 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
Interpace Diagnostics Group, Inc. closed its last trading session at $2.15 with the gain of 28.37%. The Market Capitalization of the company stands at 18.52 Million. The Company has 52-week high of $19.80 and 52-week low of $0.70. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 15.36% where SMA50 and SMA200 are 6.01% and -11.89% respectively. The Company Touched its 52-Week High on 12/09/16 and 52-Week Low on 11/22/16.
The Relative Volume of the company is 56.39 and Average Volume (3 months) is 1.01 million. Interpace Diagnostics Group, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -16.8%. The Return on Equity (ROE) value stands at -172.2%. While it’s Return on Investment (ROI) value is -43.6%.
While looking at the Stock’s Performance, Interpace Diagnostics Group, Inc. currently shows a Weekly Performance of 22.67%, where Monthly Performance is 22.67%, Quarterly performance is -43.21%, 6 Months performance is 72.5% and yearly performance percentage is -48.89%. Year to Date performance value (YTD perf) value is -37.27%. The Stock currently has a Weekly Volatility of 17.91% and Monthly Volatility of 14.96%.